These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 8033208)

  • 21. E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions.
    Oswald F; Lovec H; Möröy T; Lipp M
    Oncogene; 1994 Jul; 9(7):2029-36. PubMed ID: 8208548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. G1/S-regulated E2F-containing protein complexes bind to the mouse thymidine kinase gene promoter.
    Dou QP; Zhao S; Levin AH; Wang J; Helin K; Pardee AB
    J Biol Chem; 1994 Jan; 269(2):1306-13. PubMed ID: 8288595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association with E2F-1 governs intracellular trafficking and polyubiquitination of DP-1.
    Magae J; Illenye S; Chang YC; Mitsui Y; Heintz NH
    Oncogene; 1999 Jan; 18(3):593-605. PubMed ID: 9989809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of distinct roles for separate E1A domains in disruption of E2F complexes.
    Ikeda MA; Nevins JR
    Mol Cell Biol; 1993 Nov; 13(11):7029-35. PubMed ID: 8413292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes.
    Beijersbergen RL; Carlée L; Kerkhoven RM; Bernards R
    Genes Dev; 1995 Jun; 9(11):1340-53. PubMed ID: 7797074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F.
    Hiyama H; Iavarone A; Reeves SA
    Oncogene; 1998 Mar; 16(12):1513-23. PubMed ID: 9569018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclin E-induced S phase without activation of the pRb/E2F pathway.
    Lukas J; Herzinger T; Hansen K; Moroni MC; Resnitzky D; Helin K; Reed SI; Bartek J
    Genes Dev; 1997 Jun; 11(11):1479-92. PubMed ID: 9192874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of E2F-1 gene expression by p130 (Rb2) and D-type cyclin kinase activity.
    Johnson DG
    Oncogene; 1995 Nov; 11(9):1685-92. PubMed ID: 7478595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Release of cell cycle constraints in mouse melanocytes by overexpressed mutant E2F1E132, but not by deletion of p16INK4A or p21WAF1/CIP1.
    Halaban R; Cheng E; Zhang Y; Mandigo CE; Miglarese MR
    Oncogene; 1998 May; 16(19):2489-501. PubMed ID: 9627115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of Rb and E2F by signal transduction cascades: divergent effects of JNK1 and p38 kinases.
    Wang S; Nath N; Minden A; Chellappan S
    EMBO J; 1999 Mar; 18(6):1559-70. PubMed ID: 10075927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphorylation of E2F-1 modulates its interaction with the retinoblastoma gene product and the adenoviral E4 19 kDa protein.
    Fagan R; Flint KJ; Jones N
    Cell; 1994 Sep; 78(5):799-811. PubMed ID: 8087847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint.
    Krek W; Xu G; Livingston DM
    Cell; 1995 Dec; 83(7):1149-58. PubMed ID: 8548802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional interplay between p53 and E2F through co-activator p300.
    Lee CW; Sørensen TS; Shikama N; La Thangue NB
    Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of p21waf1 leads to increased inhibition of E2F-1 phosphorylation and sensitivity to anticancer drugs in retinoblastoma-negative human sarcoma cells.
    Li WW; Fan J; Hochhauser D; Bertino JR
    Cancer Res; 1997 Jun; 57(11):2193-9. PubMed ID: 9187120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases.
    Wang H; Shao N; Ding QM; Cui J; Reddy ES; Rao VN
    Oncogene; 1997 Jul; 15(2):143-57. PubMed ID: 9244350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F.
    Leone G; DeGregori J; Sears R; Jakoi L; Nevins JR
    Nature; 1997 May; 387(6631):422-6. PubMed ID: 9163430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulated ectopic expression of cyclin D1 induces transcriptional activation of the cdk inhibitor p21 gene without altering cell cycle progression.
    Hiyama H; Iavarone A; LaBaer J; Reeves SA
    Oncogene; 1997 May; 14(21):2533-42. PubMed ID: 9191053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon-alpha inhibits cyclin E- and cyclin D1-dependent CDK-2 kinase activity associated with RB protein and E2F in Daudi cells.
    Zhang K; Kumar R
    Biochem Biophys Res Commun; 1994 Apr; 200(1):522-8. PubMed ID: 8166726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accumulation of cyclin B1 requires E2F and cyclin-A-dependent rearrangement of the anaphase-promoting complex.
    Lukas C; Sørensen CS; Kramer E; Santoni-Rugiu E; Lindeneg C; Peters JM; Bartek J; Lukas J
    Nature; 1999 Oct; 401(6755):815-8. PubMed ID: 10548110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E2F site.
    Schulze A; Zerfass K; Spitkovsky D; Middendorp S; Bergès J; Helin K; Jansen-Dürr P; Henglein B
    Proc Natl Acad Sci U S A; 1995 Nov; 92(24):11264-8. PubMed ID: 7479977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.